Tajikistan Medical Device Installation, Repair and Metrological Maintenance
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Tajikistan imposes four requirements on the installation, repair, technical and metrological maintenance of medical products: the implementing entity must be authorized by law, the safety level after repair must not be lower than the level stated in the technical passport, the organization of servicing follows the legislation, and the list of measuring instruments is approved by the Ministry of Health together with the metrology authority. Article 37 of Law No. 1893 contains 4 paragraphs in total and is one of the few provisions in this medicines-centered law that specifically addresses the later stage of the equipment product life cycle. GRZAN notes that the technical passport in Article 37(2) is the key concept for understanding equipment compliance in Tajikistan: it serves both as the technical registration file and as the determination benchmark for the safety level after repair.
2. Legal basis
| Item | Content |
|---|---|
| Legal basis | Law of the Republic of Tajikistan on Medicines, Medical Products and Pharmaceutical Activities, No. 1893 of July 19, 2022 (re-enacted by Law No. 2181 of May 14, 2025) |
| Article 37(1) | The installation, repair, technical and metrological maintenance of medical products is carried out by natural persons and legal entities authorized under the legislation of the Republic of Tajikistan to perform these works |
| Article 37(2) | The safety level of medical equipment after repair must not be lower than the safety level stated in the technical passport |
| Article 37(3) | The organization of technical and metrological servicing of medical equipment and instruments is carried out in accordance with the legislation of the Republic of Tajikistan |
| Article 37(4) | The list of medical equipment and instruments that are measuring instruments is approved by the authorized state body in the healthcare sector together with the authorized state body in the field of technical and metrological regulation |
| Withdrawal link | Article 21(1)(12): discovery during use of a medical product of defects in design, operating principle or manufacture execution that affect the safety of its use |
| Technical testing | Article 33(2): technical testing examines the quality and safety of a product when used for the intended purpose defined in the manufacturer’s documents |
| Liability provision | Article 47(3): where damage is caused by the incorrect or unreasonable prescription or use of medicines, medical products and quasi-medicinal products, compensation is borne by the healthcare institution or the medical worker |
3. Expert insights
Insight 1: Article 37(2) establishes the technical passport as the benchmark document for safety levels, the core compliance concept for equipment products. The provision requires that the safety level after repair not be lower than the level stated in the technical passport. Its legal effect is that the safety level stated in the technical passport is a floor that can never be lowered; repair, modification and software upgrades may not reduce it. GRZAN recommends that, when compiling the technical passport, the safety level be broken down into verifiable specific indicators covering electrical safety, mechanical safety, radiation safety and software functional safety, rather than expressed in general terms.
Insight 2: Article 37(1) and Article 37(3) point the qualifications of implementing entities and service organizations to Tajik legislation. Both paragraphs use the formulation in accordance with the legislation of the Republic of Tajikistan without enumerating specific qualifications. The GRZAN interpretation is that service provider qualifications may involve several tiers of legislation, including the law on licensing and legislation in the field of technical regulation. When selecting a local service provider, companies should require the provider to present the relevant qualification documents and include a qualification maintenance obligation in the agreement.
Insight 3: Article 37 and Article 21(1)(12) form a complete risk chain. Article 21(1)(12) provides that where defects in design, operating principle or manufacture execution affecting the safety of use are discovered during the use of a medical product, the supervisory authority must withdraw it from circulation, while Article 37(2) requires that repair not reduce the safety level. Read together, the meaning is that improper repair that lowers the safety level may simultaneously trigger a violation of Article 37(2) and a withdrawal under Article 21. This risk chain imposes substantive requirements on the after-sales management of equipment products.
Insight 4: Article 47(3) assigns liability for damage caused by incorrect or unreasonable prescription or use to the healthcare institution or the medical worker. The relationship between this provision and Article 37 is as follows: Article 37 governs the installation, repair and metrology of the equipment itself, while Article 47(3) governs attribution in the use stage. The dividing line is clear: problems of equipment condition fall under Article 37, and problems of use behavior fall under Article 47. When handling adverse events, companies should make this distinction first and then determine the response pathway.
Insight 5: Article 37 is the only provision in this volume covering the entire later life cycle, and its very existence shows the legislator considered the particularities of equipment. The overwhelming majority of the provisions of Law No. 1893, covering registration, review, labelling, advertising and withdrawal, apply uniformly to medicines and devices, whereas Article 37 specifically addresses installation, repair, technical and metrological maintenance, actions that are meaningful only for equipment. GRZAN recommends that, when designing a Tajik compliance program for equipment products, Article 37 be treated as a separate module covering installation acceptance, repair records, metrology cycles and service provider management.
4. Practical recommendations
- Turn the technical passport into a verifiable list of indicators. Under Article 37(2), break the safety level down in the technical passport into verifiable indicators covering electrical safety, mechanical safety, radiation safety and software functional safety, providing a determination benchmark for subsequent repairs and inspections.
- Include the qualification documents of local service providers in approved supplier reviews. Under Article 37(1) and (3), require providers to present qualifications obtained under Tajik legislation, and agree in the contract on qualification maintenance and notification obligations upon expiry.
- Establish a repair record ledger and re-verify against the technical passport. Maintain repair records for each unit of equipment, and after every repair re-verify the safety indicators against the technical passport with a written conclusion, in preparation for inspections under Article 21(1)(12).
- Incorporate metrology cycles into the equipment management system. Under Article 37(4), establish a metrological verification cycle ledger for equipment on the measuring instrument list with automatic reminders before expiry, avoiding expired verification affecting use and inspections.
- Distinguish equipment condition from use behavior first in adverse event handling. Under Article 37 and Article 47(3), determine whether the event originates from equipment condition (Article 37) or from use behavior (Article 47(3)) before fixing the response pathway and the attribution of responsibility.
5. Verification checklist
- □ It has been confirmed that the implementing entity under Article 37(1) must be authorized by law
- □ The safety level in the technical passport has been broken down into verifiable specific indicators (Article 37(2))
- □ Local service providers have presented qualification documents and maintenance obligations are agreed in the contract (Article 37(1) and (3))
- □ A repair record ledger for each unit of equipment has been established with re-verification against the technical passport
- □ A metrological verification cycle ledger has been established for equipment on the measuring instrument list (Article 37(4))
- □ The adverse event handling process distinguishes equipment condition from use behavior (Article 37, Article 47(3))
- □ The risk of improper repair triggering a withdrawal under Article 21(1)(12) has been assessed
Regulatory information verified as of October 29, 2026.
In the Central Asian market, GRZAN focuses its core capabilities on three areas. First, distinguishing the different legal positions of each market within the Eurasian Economic Union: Kazakhstan and Kyrgyzstan are full member states where a national track and a Union track coexist; Uzbekistan is an observer state with only the national track; Tajikistan and Turkmenistan lie outside the Union framework and must proceed entirely under national procedures. Second, local authorized representative services: GRZAN acts as the statutory representative of manufacturers in these countries, undertaking registration submission, regulatory communication and post-market reporting obligations. Third, quality system and testing support: GRZAN helps establish a quality management system compliant with ISO 13485 and connects clients with locally accredited laboratory resources.
Business inquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us